2008/09/22

CIC bioGUNE participates in two projects funded by NIH: liver injury and colon cancer pathogenesis.

The National Center for Complementary & Alternative Medicine (NCCAM), part of the US National Institutes of Health (NIH), has awarded two grants totaling US$ 2.57 million over a five-year period to the University of Southern California, Keck School of Medicine, in Los Angeles and CIC bioGUNE.

The first grant is for the study of the role of S-adenosylmethionine (SAMe) in liver function and injury. Total grant amount is US$ 1.29 million and the subcontract to CIC bioGUNE is US$ 512,000.
The second grant is for the study of the role of methyl-thioadenosine and SAMe in colon cancer pathogenesis and treatment. Total grant amount is US$ 1.28 million and the subcontract to CIC bioGUNE is US$ 202,000. The principal investigator (PI) of this research team is Shelly Lu, from the Keck School of Medicine. José Mato and M Luz Martínez-Chantar, from CIC bioGUNE, are co-PIs of these two projects. Shelly Lu and José Mato have been collaborating for 10 years and have co-authored 41 research papers since 1999 in prestigious scientific journals such as Gastroenterology and Hepatology.
José Mato has been co-PI of 5 previous NIH grants awarded to Shelly Lu.